rs61743284

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004758.4(TSPOAP1):​c.236G>A​(p.Gly79Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0226 in 1,613,940 control chromosomes in the GnomAD database, including 508 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.018 ( 32 hom., cov: 32)
Exomes 𝑓: 0.023 ( 476 hom. )

Consequence

TSPOAP1
NM_004758.4 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.232

Publications

9 publications found
Variant links:
Genes affected
TSPOAP1 (HGNC:16831): (TSPO associated protein 1) Enables benzodiazepine receptor binding activity. Predicted to be involved in regulation of presynaptic cytosolic calcium ion concentration. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2022]
TSPOAP1-AS1 (HGNC:44148): (TSPOAP1, SUPT4H1 and RNF43 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0019398034).
BP6
Variant 17-58327685-C-T is Benign according to our data. Variant chr17-58327685-C-T is described in ClinVar as Benign. ClinVar VariationId is 402438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.018 (2745/152348) while in subpopulation SAS AF = 0.0281 (136/4834). AF 95% confidence interval is 0.0243. There are 32 homozygotes in GnomAd4. There are 1365 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 32 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004758.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSPOAP1
NM_004758.4
MANE Select
c.236G>Ap.Gly79Glu
missense
Exon 1 of 32NP_004749.2
TSPOAP1
NM_001261835.2
c.236G>Ap.Gly79Glu
missense
Exon 1 of 32NP_001248764.1
TSPOAP1
NM_024418.3
c.236G>Ap.Gly79Glu
missense
Exon 1 of 31NP_077729.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSPOAP1
ENST00000343736.9
TSL:1 MANE Select
c.236G>Ap.Gly79Glu
missense
Exon 1 of 32ENSP00000345824.4
TSPOAP1
ENST00000268893.10
TSL:1
c.236G>Ap.Gly79Glu
missense
Exon 1 of 31ENSP00000268893.6
TSPOAP1-AS1
ENST00000579527.5
TSL:2
n.280-365C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0181
AC:
2748
AN:
152230
Hom.:
32
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00540
Gnomad AMI
AF:
0.0175
Gnomad AMR
AF:
0.0171
Gnomad ASJ
AF:
0.0510
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0285
Gnomad FIN
AF:
0.0240
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0238
Gnomad OTH
AF:
0.0239
GnomAD2 exomes
AF:
0.0217
AC:
5452
AN:
251178
AF XY:
0.0232
show subpopulations
Gnomad AFR exome
AF:
0.00536
Gnomad AMR exome
AF:
0.0119
Gnomad ASJ exome
AF:
0.0469
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0244
Gnomad NFE exome
AF:
0.0244
Gnomad OTH exome
AF:
0.0276
GnomAD4 exome
AF:
0.0231
AC:
33735
AN:
1461592
Hom.:
476
Cov.:
31
AF XY:
0.0240
AC XY:
17452
AN XY:
727110
show subpopulations
African (AFR)
AF:
0.00550
AC:
184
AN:
33478
American (AMR)
AF:
0.0122
AC:
546
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0468
AC:
1224
AN:
26136
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39700
South Asian (SAS)
AF:
0.0323
AC:
2784
AN:
86258
European-Finnish (FIN)
AF:
0.0233
AC:
1236
AN:
53130
Middle Eastern (MID)
AF:
0.0373
AC:
215
AN:
5768
European-Non Finnish (NFE)
AF:
0.0235
AC:
26098
AN:
1112006
Other (OTH)
AF:
0.0239
AC:
1443
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
2253
4506
6758
9011
11264
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
972
1944
2916
3888
4860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0180
AC:
2745
AN:
152348
Hom.:
32
Cov.:
32
AF XY:
0.0183
AC XY:
1365
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.00539
AC:
224
AN:
41580
American (AMR)
AF:
0.0171
AC:
262
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0510
AC:
177
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.0281
AC:
136
AN:
4834
European-Finnish (FIN)
AF:
0.0240
AC:
255
AN:
10622
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0237
AC:
1615
AN:
68032
Other (OTH)
AF:
0.0237
AC:
50
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
136
273
409
546
682
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0229
Hom.:
31
Bravo
AF:
0.0170
TwinsUK
AF:
0.0218
AC:
81
ALSPAC
AF:
0.0210
AC:
81
ESP6500AA
AF:
0.00749
AC:
33
ESP6500EA
AF:
0.0260
AC:
224
ExAC
AF:
0.0217
AC:
2633
Asia WGS
AF:
0.0120
AC:
43
AN:
3478
EpiCase
AF:
0.0267
EpiControl
AF:
0.0279

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
12
DANN
Benign
0.69
DEOGEN2
Benign
0.0089
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.64
D
LIST_S2
Benign
0.64
T
MetaRNN
Benign
0.0019
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.97
L
PhyloP100
0.23
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.75
N
REVEL
Benign
0.078
Sift
Benign
0.066
T
Sift4G
Benign
0.33
T
Polyphen
0.68
P
Vest4
0.065
MPC
0.27
ClinPred
0.0023
T
GERP RS
0.89
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.064
gMVP
0.085
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61743284; hg19: chr17-56405046; COSMIC: COSV52108730; COSMIC: COSV52108730; API